Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Balsm Alofoq Medical CoSAU:9620 21 Days Payable is 28.25 as of Jun. 2026, which is 192% above its 10-year median of 9.69. GuruFocus rates SAU:9620 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Balsm Alofoq Medical Co ranks worse than 93.35% on this metric.
The historical rank and industry rank for Balsm Alofoq Medical Co's Days Payable or its related term are showing as below:
SAU:9620'
s Days Payable Range Over the Past 10 Years
Min: 7.6 Med: 9.69 Max: 20.12
Current: 20.12
During the past 4 years, Balsm Alofoq Medical Co's highest Days Payable was 20.12. The lowest was 7.60. And the median was 9.69.
SAU:9620's Days Payable is ranked worse than 93.35% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 69.48
vs SAU:9620: 20.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balsm Alofoq Medical Co Days Payable Chart
Balsm Alofoq Medical Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Days Payable
18.21
14.21
10.52
7.55
Balsm Alofoq Medical Co Semi-Annual Data
Jun25
Dec25
Jun26
Days Payable
30.90
27.86
28.25
SAU:9620 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Balsm Alofoq Medical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balsm Alofoq Medical Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Balsm Alofoq Medical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Balsm Alofoq Medical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Balsm Alofoq Medical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Balsm Alofoq Medical Co (SAU:9620) has a Days Payable of 28.25 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Balsm Alofoq Medical Co and its competitors. This is 192% above median its historical median of 9.69. Over the past decade, Balsm Alofoq Medical Co's Days Payable has ranged from 7.60 to 20.12. According to the industry distribution chart, Balsm Alofoq Medical Co ranks #744 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 93.4%.
Is Balsm Alofoq Medical Co's Days Payable too high?
Balsm Alofoq Medical Co's current Days Payable of 28.25 is 192% above median its 10-year median of 9.69. Over the past 10 years, this metric has ranged from a low of 7.60 to a high of 20.12. The Medical Devices & Instruments industry median Days Payable is 69.48. Balsm Alofoq Medical Co's value of 28.25 is 59.3% below this industry median. Based on the distribution chart, Balsm Alofoq Medical Co ranks #744 out of 797 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Balsm Alofoq Medical Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Balsm Alofoq Medical Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Balsm Alofoq Medical Co ranks #744 out of 797 companies for Days Payable. This places Balsm Alofoq Medical Co in the lower half of its industry. The industry median Days Payable is 69.48. Balsm Alofoq Medical Co's value of 28.25 is 59.3% below this benchmark. Historically, Balsm Alofoq Medical Co's own Days Payable has ranged from 7.60 to 20.12 over the past decade. While the company's 10-year median is 9.69 vs. the industry median of 69.48, Balsm Alofoq Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 69.48, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balsm Alofoq Medical Co's current Days Payable of 28.25 is 59.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Balsm Alofoq Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 69.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balsm Alofoq Medical Co's current Days Payable is 28.25, which is 192% above median its own 10-year median of 9.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balsm Alofoq Medical Co stock overvalued right now?
Balsm Alofoq Medical Co (SAU:9620) has a current Days Payable of 28.25. The current Days Payable is 28.25, which is 192% above median its 10-year median of 9.69 and 59.3% below the Medical Devices & Instruments industry median of 69.48. Balsm Alofoq Medical Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Balsm Alofoq Medical Co (SAU:9620), the current Days Payable is 28.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Balsm Alofoq Medical Co is a Saudi Arabian healthcare company operating in the medical services and medical supply sectors. Its activities include the operation of medical services, specialized clinics, and medical complexes, as well as the performance of medical operations. In addition, the company is engaged in the import and supply of medical devices and medical supplies, distributing these products across all regions of the Kingdom of Saudi Arabia. The company serves patients through its clinics and medical complexes while also supplying healthcare providers, hospitals, and other medical institutions with devices and consumables. Its revenue is generated through the provision of clinical and medical services and through the sale and distribution of imported medical equipment and supplies. The company operates primarily within the Saudi Arabian market, where its medical services and distribution activities are concentrated.
21GF Score
Get the complete analysis for SAU:9620
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9620 has been successfully added to your 
